What is the current valuation of the US intravenous solution market?

The market valuation was $3150.0 Million in 2024. Read More

What is the projected market size for the US intravenous solution market by 2035?

The market is expected to reach $8000.0 Million by 2035. Read More

What is the expected CAGR for the US intravenous solution market during the forecast period 2025 - 2035?

The expected CAGR is 8.84% during the forecast period. Read More

Which companies are the key players in the US intravenous solution market?

Key players include Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG, and others. Read More

What are the main segments of the US intravenous solution market?

The main segments include Nutrition Type, Bag Type, Nutritional Content, and End User. Read More

What was the market size for Total Parenteral Nutrition in 2024?

The market size for Total Parenteral Nutrition was $2520.0 Million in 2024. Read More

How much is the market for Large Volume Bags projected to grow by 2035?

The market for Large Volume Bags is projected to grow from $1890.0 Million to $4600.0 Million by 2035. Read More

What is the market size for Parenteral Lipid Emulsion in 2024?

The market size for Parenteral Lipid Emulsion was $945.0 Million in 2024. Read More

Which end user segment had the highest market size in 2024?

The Hospital & Clinics segment had the highest market size at $1890.0 Million in 2024. Read More

What is the projected market size for Home Care by 2035?

The market size for Home Care is projected to reach $1900.0 Million by 2035. Read More

How much is the market projected to grow by 2035?

By 2035, the market is anticipated to reach a value of 9.0 billion USD. Read More

What is the expected CAGR for the market from 2025 to 2035?

The US Intravenous Solution Market is expected to grow at a CAGR of 7.651 percent from 2025 to 2035. Read More

What is the market size for Total Parenteral Nutrition in 2024?

The market for Total Parenteral Nutrition is estimated to be valued at 2.4 billion USD in 2024. Read More

How much will the market for Peripheral Parenteral Nutrition be worth in 2035?

The market for Peripheral Parenteral Nutrition is projected to reach 3.6 billion USD by 2035. Read More

What growth factors are driving the US Intravenous Solution Market?

The growth is driven by increasing healthcare needs and advances in medical technology. Read More

Are there any emerging trends in the US Intravenous Solution Market?

Yes, there is a trend towards personalized nutrition and advancements in delivery systems. Read More

What challenges does the US Intravenous Solution Market currently face?

Challenges include stringent regulations and the need for advanced manufacturing technologies. Read More

How does the growth rate of the market segment for Total Parenteral Nutrition compare to Peripheral Parenteral Nutrition from 2025 to 2035?

Both segments are expected to grow significantly, but Total Parenteral Nutrition will see a larger market expansion. Read More

US Intravenous Solution Market

ID: MRFR/MED/11877-HCR

200 Pages

Nidhi Mandole

Last Updated: April 24, 2026

US Intravenous Solution Market Research Report: Size, Share, Trend Analysis By Nutrition Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), By Bag Type (Large Volume Bags (>250 ml), Small Volume Bags (250 ml), By Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins Minerals, Parenteral Lipid Emulsion) and By End Users (Hospital Clinics, Ambulatory Surgical Centers, Home Care) - Growth Outlook & Industry Forecast 2025 To 2035

US Intravenous Solution Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Nutrition Type (USD Million)
  1. 4.1.1 Peripheral Parenteral Nutrition
  2. 4.1.2 Total Parenteral Nutrition
2. 4.2 Life Sciences, BY Bag Type (USD Million)
  1. 4.2.1 Large Volume Bags (>250 ml)
  2. 4.2.2 Small Volume Bags (<250 ml)
3. 4.3 Life Sciences, BY Nutritional Content (USD Million)
  1. 4.3.1 Amino Acid Solution
  2. 4.3.2 Carbohydrates
  3. 4.3.3 Vitamins & Minerals
  4. 4.3.4 Parenteral Lipid Emulsion
  5. 4.3.5 Others
4. 4.4 Life Sciences, BY End User (USD Million)
  1. 4.4.1 Hospital & Clinics
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Home Care
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Baxter International (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 B. Braun Melsungen AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Fresenius Kabi AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Hospira (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Terumo Corporation (JP)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Otsuka Pharmaceutical Co., Ltd. (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Grifols S.A. (ES)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eagle Pharmaceuticals, Inc. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Sagent Pharmaceuticals, Inc. (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY NUTRITION TYPE
3. 6.3 US MARKET ANALYSIS BY BAG TYPE
4. 6.4 US MARKET ANALYSIS BY NUTRITIONAL CONTENT
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY NUTRITION TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY NUTRITION TYPE, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY BAG TYPE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY BAG TYPE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY NUTRITIONAL CONTENT, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY NUTRITIONAL CONTENT, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY NUTRITION TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY BAG TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY NUTRITIONAL CONTENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Life Sciences Market Segmentation

Life Sciences By Nutrition Type (USD Million, 2025-2035)

Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Life Sciences By Bag Type (USD Million, 2025-2035)

Large Volume Bags (>250 ml)
Small Volume Bags (<250 ml)

Life Sciences By Nutritional Content (USD Million, 2025-2035)

Amino Acid Solution
Carbohydrates
Vitamins & Minerals
Parenteral Lipid Emulsion
Others

Life Sciences By End User (USD Million, 2025-2035)

Hospital & Clinics
Ambulatory Surgical Centers
Home Care

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”